Published in PLoS Curr on April 09, 2013
Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal Melanoma | NCT01585194
Pathways and therapeutic targets in melanoma. Oncotarget (2014) 1.17
Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol (2014) 1.13
Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res (2014) 0.99
A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology (2014) 0.91
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses. Clin Ophthalmol (2014) 0.84
Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy. Am J Ophthalmol (2014) 0.78
Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma. JAMA Ophthalmol (2016) 0.78
Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism. Graefes Arch Clin Exp Ophthalmol (2014) 0.77
EMT-associated factors promote invasive properties of uveal melanoma cells. Mol Vis (2015) 0.77
Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations. PLoS One (2016) 0.76
Ocular tumors: Triumphs, challenges and controversies. Saudi J Ophthalmol (2013) 0.75
Clinical application of genetic testing for posterior uveal melanoma. Int J Retina Vitreous (2016) 0.75
The biology of uveal melanoma. Cancer Metastasis Rev (2017) 0.75
Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83
Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85
Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci (2003) 2.58
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn (2010) 2.48
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw (2011) 2.24
Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res (2007) 2.15
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res (2006) 2.03
Prognosis and treatment of disseminated uveal melanoma. Cancer (1993) 1.98
Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol (2009) 1.82
Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res (2010) 1.80
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res (2008) 1.54
The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med (2007) 1.50
The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med (2009) 1.45
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye (Lond) (2007) 1.35
Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci (2008) 1.32
A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res (2008) 1.26
Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci (2010) 1.23
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy. Cancer Immunol Immunother (2011) 1.19
Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo. Ophthalmology (2006) 1.16
Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.15
Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med (2009) 1.04
In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Ophthalmol (2006) 0.97
Reactions to and desire for prognostic testing in choroidal melanoma patients. J Genet Couns (2009) 0.96
Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye (Lond) (2008) 0.93
Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization. Arch Ophthalmol (2009) 0.93
Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol (2012) 0.89
A pilot study of sunitinib malate in patients with metastatic uveal melanoma. Melanoma Res (2012) 0.89
Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment. Rofo (2011) 0.78
Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 3.09
Fundus autofluorescence imaging in a patient with rapidly developing scotoma. Retin Cases Brief Rep (2012) 0.95
Macular dystrophy in Heimler syndrome. Ophthalmic Genet (2011) 0.79